Stockreport

Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases
PDF Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended mechanisti [Read more]